(207 days)
No
The summary describes a mechanical spinal plate and screw system with no mention of AI or ML capabilities.
Yes
The device is described as a "Synthes TiLPS" intended for "anterior intravertebral body screw fixation/attachment to the LI-S1 spine" to "stabilization and buttressing of bone graft over one motion segment following anterior structural reconstruction for degenerative disc disease," which clearly indicates a therapeutic purpose.
No
This device is described as a "screw fixation/attachment" system and a "bone graft" stabilizer, used for "stabilization and buttressing" of the spine. Its purpose is to physically support and stabilize, not to diagnose medical conditions.
No
The device description clearly states it consists of a plate and screws, which are physical hardware components.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Description: The Synthes TiLPS is a surgical implant (plate and screws) intended for stabilizing the spine. It is a physical device implanted into the body, not a test performed on a sample outside the body.
- Intended Use: The intended use describes a surgical procedure for spinal stabilization, not a diagnostic test.
Therefore, the Synthes TiLPS falls under the category of a surgical implant or device, not an in vitro diagnostic.
N/A
Intended Use / Indications for Use
The Synthes TiLPS is intended for anterior intravertebral body screw fixation/attachment to the LI-SI spine over one vertebral body extending onto the adjacent intervetebral space. Due to variations in the anatomy, the plate is designed for applications caudal to the bifurcation of the great vessels. Specifically, the device is intended for stabilization and buttressing of bone graft over one motion segment following anterior structural reconstruction for degenerative disc disease. DDD is defined as follows: back pain of a discogenic origin with degeneration of the disc confirmed by history and radiographic studies
Product codes
KWQ
Device Description
The system consists of a two hole locking plate, 4.35 mm expansion screws with 1.8 mm locking screws. The two hole plate is available in various lengths and is manufactured from commercially pure titanium. The TiLPS is intended to be used as follows: The placed against the anterior aspect of the vertebral body, the 4.35 mm expansion screw is inserted through the holes of the Titanium Locking Plate into the vertebral body, and tightened until the screw head is fully seated in the plate. At this point, the 1.8 mm screw with locking head is inserted into the 4.35 mm expansion screw by way of the mating threads (1.8 mm) on these parts. As the locking screw is tightened, the conical head of this screw engages the conical bore within the head of the expansion screw. In addition to the conical bore, the head of the expansion screw is slotted so that further tightening of the locking screw serves to expand the four sections of the expansion screw head outward. This outward (radial) expansion of the 4.35 mm expansion screw head creates locking force between the screw and plate. Implant removal is accomplished in reverse order. The TiLPS is similar in plate width, thickness and length to the Anterior Cervical Vertebrae Plate System and is manufactured from the same material. The plate attaches to the bone through the use of an expansion screw with a locking screw.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
LI-S1 spine, vertebral body
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Not Found
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 888.3060 Spinal intervertebral body fixation orthosis.
(a)
Identification. A spinal intervertebral body fixation orthosis is a device intended to be implanted made of titanium. It consists of various vertebral plates that are punched into each of a series of vertebral bodies. An eye-type screw is inserted in a hole in the center of each of the plates. A braided cable is threaded through each eye-type screw. The cable is tightened with a tension device and it is fastened or crimped at each eye-type screw. The device is used to apply force to a series of vertebrae to correct “sway back,” scoliosis (lateral curvature of the spine), or other conditions.(b)
Classification. Class II.
0
AUG - I 1997
Summary of Safety and Effectiveness Information
Synthes (USA) 1690 Russell Road Paoli, PA 19301
(610) 647-9700 Contact: Barry E. Sands
Synthes Titanium Locking Plate System (TiLPS) is compared to the Synthes Anterior Cervical Vertebrae Plate System (K926453 and K945700), and the Synthes Anterior Spinal Plate System (K925351).
The Synthes TiLPS is intended for anterior intravertebral body screw fixation/attachment to the LI-S1 spine over one vertebral body extending onto the adjacent intervetebral space. Due to variations in the anatomy, the plate is designed for applications caudal to the bifurcation of the great vessels. Specifically, the device is intended for stabilization and buttressing of bone graft over one motion segment following anterior structural reconstruction for degenerative disc disease.
DDD is defined as follows: back pain of a discogenic origin with degeneration of the disc confirmed by history and radiographic studies
The system consists of a two hole locking plate, 4.35 mm expansion screws with 1.8 mm locking screws. The two hole plate is available in various lengths and is manufactured from commercially pure titanium.
The TiLPS is intended to be used as follows: The placed against the anterior aspect of the vertebral body, the 4.35 mm expansion screw is inserted through the holes of the Titanium Locking Plate into the vertebral body, and tightened until the screw head is fully seated in the plate. At this point, the 1.8 mm screw with locking head is inserted into the 4.35 mm expansion screw by way of the mating threads (1.8 mm) on these parts. As the locking screw is tightened, the conical head of this screw engages the conical bore within the head of the expansion screw. In addition to the conical bore, the head of the expansion screw is slotted so that further tightening of the locking screw serves to expand the four sections of the expansion screw head outward. This outward (radial) expansion of the 4.35 mm expansion screw head creates locking force between the screw and plate. Implant removal is accomplished in reverse order.
The TiLPS is similar in plate width, thickness and length to the Anterior Cervical Vertebrae Plate System and is manufactured from the same material. The plate attaches to the bone through the use of an expansion screw with a locking screw.
Based on this information, Synthes Titanium Locking Plate System is substantially equivalent to Synthes Anterior Cervical Vertebrae Plate System and Synthes Anterior Spinal Plate System.
1
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Mr. Barry E. Sands -Manager, Requlatory Affairs Synthes Spine 1690 Russell Road P.O. Box 1766 Paoli, Pennsylvania 19301
AUG - 1 1997
Re: K970048 Trade Name: Synthes Titanium Locking Plate System Requlatory Class: II Product Code: KWQ Dated: May 5, 1997 Received: May 7, 1997
Dear Mr. Sands:
We have reviewed your Section 510(k) notification of intent to market the device system referenced above and we have determined the device system is substantially equivalent (for the indications for use stated in the enclosure) to device systems marketed in interstate commerce prior to May 28, 1976 or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act You may, therefore, market your device system subject (Act) . . to the general controls provisions of the Act and the limitations identified below.
The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Note that labeling or otherwise promoting this device system for pedicular screw fixation/attachment would cause the device system to be adulterated under 501(f) (1) of the Act.
2
Page 2 - Mr. Barry E. Sands
FDA identifies that any device system, if intended for use in pedicular screw fixation/attachment, except for some limited indications, would be found not substantially equivalent and would be a class III device under Section 513(f) of the Act. Class III devices are required to have an approved premarket approval (PMA) application prior to marketing. Accordingly:
-
- You may not label or in any way promote this device system for pedicular screw attachment to, or fixation of the cervical, thoracic or lumbar vertebral column. Therefore, in order to prevent off-label promotion, the package insert must include the following statement, "WARNING: This device system is not approved for screw attachment or fixation to the posterior elements (pedicles) of the cervical, thoracic, or lumbar spine.";
-
- All labeling for this device system, including the package label, must state that there are labeling limitations. The package insert must prominently state that the device system is intended for the specific use(s) described in the enclosure only; and
-
- Pedicular screw fixation/attachment to the cervical, thoracic or lumbar vertebral column, except for limited indications, of any device system is considered investigational and may only be investigated as a significant risk device in accordance with the investigational device exemption (IDE) regulations under 21 CFR, Part 812. All users of the device system for pedicular screw fixation/attachment must receive approval from their respective institutional review boards (IRBs) and the Food and Drug Administration (FDA) prior to conducting an investigation.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. ਸੇ substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (QS) for Medical
3
Page 3 - Mr. Barry E. Sands
Devices: General requlation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements --------------------------------------------------------------------------------concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal Laws or Requlations.
FDA advises that the use of the subject device system and/or device components with any other device components but those identified in this 510(k) would require submission of a new 510 (k) providing documentation of design, material, and labeling compatibility between the device components. Mechanical testing of a spinal system consisting of the subject device components and other device components, whether yours or other manufacturers', may also be required.
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification immediately. An FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be
4
Page 4 - Mr. Barry E. Sands
obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address "http://www.fda.gov/cdrh/dsmamain.html".
Sincerely yours,
Celia M. Witten, Ph.D., M.D.
Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
Image /page/5/Picture/0 description: The image shows the logo for Synthes Spine. The logo consists of a circular symbol with a stylized image inside, followed by the word "SYNTHES" in bold, sans-serif font. Below "SYNTHES" is the word "Spine" in a similar but slightly smaller font. The logo is black and white.
Page 1 of 1
510(k) Number (if known): K970048
Device Name: __Synthes (USA) Titanium Locking Plate System
Indications for Use:
The Synthes TiLPS is intended for anterior intravertebral body screw fixation/attachment to the LI-SI spine over one vertebral body extending onto the adjacent intervetebral space. Due to variations in the anatomy, the plate is designed for applications caudal to the bifurcation of the great vessels. Specifically, the device is intended for stabilization and buttressing of bone graft over one motion segment following anterior structural reconstruction for degenerative disc disease.
DDD is defined as follows: back pain of a discogenic origin with degeneration of the disc confirmed by history and radiographic studies
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use (Per 21 CFR 801.109) OR
Over-the-Counter Use